These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38960460)

  • 1. Maintenance proton pump inhibitor use and risk of colorectal cancer: a Swedish retrospective cohort study.
    Liu Q; Wang X; Engstrand L; Sadr-Azodi O; Fall K; Brusselaers N
    BMJ Open; 2024 Jul; 14(7):e079591. PubMed ID: 38960460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
    Brusselaers N; Wahlin K; Engstrand L; Lagergren J
    BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden.
    Brusselaers N; Sadr-Azodi O; Engstrand L
    J Gastroenterol; 2020 Apr; 55(4):453-461. PubMed ID: 31811561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance Proton Pump Inhibitor Use Associated with Increased All-Cause and Cause-Specific Mortality in Sweden.
    Ngwenya S; Simin J; Brusselaers N
    Dig Dis Sci; 2023 Jun; 68(6):2252-2263. PubMed ID: 36629968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
    Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
    Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
    Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
    BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.
    Poulsen AH; Christensen S; McLaughlin JK; Thomsen RW; Sørensen HT; Olsen JH; Friis S
    Br J Cancer; 2009 May; 100(9):1503-7. PubMed ID: 19352380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
    Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
    J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of proton pump inhibitors versus histamine-2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers.
    Fan HP; Zhou Y; Chen ML; Qiu KH; Feng X; Zhou C; Zhu ML; Huang RZ; Hu TY
    Pharmacotherapy; 2024 Jul; 44(7):539-548. PubMed ID: 38899757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study.
    Zeng R; Ma Y; Zhang L; Luo D; Jiang R; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    Elife; 2024 Jul; 13():. PubMed ID: 39012339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance proton pump inhibition therapy and risk of oesophageal cancer.
    Brusselaers N; Engstrand L; Lagergren J
    Cancer Epidemiol; 2018 Apr; 53():172-177. PubMed ID: 29477057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
    Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
    Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden.
    Brusselaers N; Lagergren J
    BMJ Open; 2018 Jul; 8(7):e021869. PubMed ID: 29982219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Use of Acid Suppressants and Risk of Dementia in the Elderly: A Pharmaco-Epidemiological Cohort Study.
    Chen LY; Lin HJ; Wu WT; Chen YC; Chen CL; Kao J; You SL; Chou YC; Sun CA
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    BMJ Open; 2017 Jul; 7(6):e015735. PubMed ID: 28676480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of daily treatment with acid suppressants for stress ulcer prophylaxis on risk of ventilator-associated events.
    Li X; Klompas M; Menchaca JT; Young JG
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):187-193. PubMed ID: 31818336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists.
    Patel KS; Stephany BR; Barnes JF; Bauer SR; Spinner ML
    Pharmacotherapy; 2017 Dec; 37(12):1507-1515. PubMed ID: 28976570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.